Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:46 PM
Ignite Modification Date:
2025-12-24 @ 3:46 PM
NCT ID:
NCT01021592
Eligibility Criteria:
Inclusion Criteria:
* Patients who are newly prescribed bortezomib injection as a secondary agent for the treatment of multiple myeloma
* Patients who can understand and fill out quality of life questionnaires, and who agree to provide information will be included
Exclusion Criteria:
* Patients who are hypersensitive to the bortezomib or any component of bortezomib or with a history of the hypersensitivity
* Patients with severe hepatic impairment
* Pregnant women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01021592
Study Brief:
Protocol Section:
NCT01021592